Mark Ebert

980 total citations
23 papers, 722 citations indexed

About

Mark Ebert is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Mark Ebert has authored 23 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Pathology and Forensic Medicine and 7 papers in Surgery. Recurrent topics in Mark Ebert's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (11 papers) and Cancer and Skin Lesions (3 papers). Mark Ebert is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (11 papers) and Cancer and Skin Lesions (3 papers). Mark Ebert collaborates with scholars based in United States, Austria and Germany. Mark Ebert's co-authors include Charles E. Cox, Alan Cantor, Douglas S. Reintgen, Elisabeth Dupont, Keoni Nguyen, Eric Peltz, Sheila Sheth, Elliot K. Fishman, Alan R. Shons and Christopher Salud and has published in prestigious journals such as Annals of Surgery, The American Journal of Surgical Pathology and Plastic & Reconstructive Surgery.

In The Last Decade

Mark Ebert

21 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Ebert United States 13 435 357 354 164 83 23 722
Steffi Hartmann Germany 15 454 1.0× 356 1.0× 272 0.8× 169 1.0× 48 0.6× 43 746
Mediget Teshome United States 15 537 1.2× 342 1.0× 377 1.1× 344 2.1× 90 1.1× 74 961
Lukas Rettenbacher Austria 14 206 0.5× 204 0.6× 442 1.2× 117 0.7× 70 0.8× 50 697
Christine Dauphine United States 16 229 0.5× 196 0.5× 577 1.6× 470 2.9× 100 1.2× 54 939
Rauni Saaristo Finland 12 254 0.6× 149 0.4× 319 0.9× 213 1.3× 65 0.8× 18 591
F. Haddad United States 13 491 1.1× 401 1.1× 451 1.3× 410 2.5× 145 1.7× 44 1.1k
Kathryn Evers United States 16 253 0.6× 219 0.6× 161 0.5× 270 1.6× 166 2.0× 30 738
Olga M. B. Gatewood United States 15 285 0.7× 394 1.1× 240 0.7× 121 0.7× 184 2.2× 32 785
M. Pamilo Finland 13 220 0.5× 223 0.6× 219 0.6× 295 1.8× 175 2.1× 40 688
Leo J. Mahoney Canada 11 925 2.1× 554 1.6× 298 0.8× 454 2.8× 99 1.2× 23 1.2k

Countries citing papers authored by Mark Ebert

Since Specialization
Citations

This map shows the geographic impact of Mark Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ebert more than expected).

Fields of papers citing papers by Mark Ebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ebert. The network helps show where Mark Ebert may publish in the future.

Co-authorship network of co-authors of Mark Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ebert. A scholar is included among the top collaborators of Mark Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ebert. Mark Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ebert, Mark, et al.. (2019). Synergy theory for murine Harderian gland tumours after irradiation by mixtures of high-energy ionized atomic nuclei. Radiation and Environmental Biophysics. 58(2). 151–166. 12 indexed citations
2.
Haug, Peter J., Jeffrey P. Ferraro, John Holmén, et al.. (2013). An ontology-driven, diagnostic modeling system. Journal of the American Medical Informatics Association. 20(e1). e102–e110. 35 indexed citations
3.
4.
Ebert, Mark, Ojan Assadian, N.-O. Hübner, Torsten Koburger, & Axel Krämer. (2011). Antimicrobial Efficacy of the Silver Wound Dressing Biatain Ag in a Disc Carrier Test Simulating Wound Secretion. Skin Pharmacology and Physiology. 24(6). 337–341. 8 indexed citations
5.
Ebert, Mark, Sheila Sheth, & Elliot K. Fishman. (2008). Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of “mayhem in the lung”. Emergency Radiology. 16(2). 159–162. 15 indexed citations
6.
Jakub, James W., Mark Ebert, Alan Cantor, et al.. (2004). Breast Cancer in Patients with Prior Augmentation: Presentation, Stage, and Lymphatic Mapping. Plastic & Reconstructive Surgery. 114(7). 1737–1742. 44 indexed citations
7.
Cox, Charles, Elisabeth Dupont, Laura White, et al.. (2004). Local recurrence in lumpectomy patients after imprint cytology margin evaluation. The American Journal of Surgery. 188(4). 349–354. 39 indexed citations
8.
Cox, Charles E., Ben Furman, Elisabeth Dupont, et al.. (2004). Novel techniques in sentinel lymph node mapping and localization of nonpalpable breast lesions: The moffit experience. Annals of Surgical Oncology. 11(S3). 222S–226S. 8 indexed citations
9.
Diaz, Nils M., Charles E. Cox, Mark Ebert, et al.. (2004). Benign Mechanical Transport of Breast Epithelial Cells to Sentinel Lymph Nodes. The American Journal of Surgical Pathology. 28(12). 1641–1645. 63 indexed citations
10.
Jakub, James W., Mark Ebert, Nils M. Diaz, et al.. (2003). Effect of Lymphatic Mapping on Diagnosis and Treatment of Patients With T1a, T1b Favorable Breast Cancer. Annals of Surgery. 237(6). 838–843. 6 indexed citations
11.
Furman, Ben, et al.. (2003). Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. The American Journal of Surgery. 186(4). 344–347. 15 indexed citations
12.
Cox, Charles E., Ben Furman, Mark Ebert, et al.. (2003). Radioactive Seed Localization Breast Biopsy and Lumpectomy: Can Specimen Radiographs Be Eliminated?. Annals of Surgical Oncology. 10(9). 1039–1047. 49 indexed citations
13.
Cox, Charles, Elisabeth Dupont, Ben Furman, et al.. (2003). The clinical relevance of positive sentinel nodes only versus positive nonsentinel lymph nodes in breast cancer patients. The American Journal of Surgery. 186(4). 333–336. 7 indexed citations
14.
Cox, Charles E., Mark Ebert, & James W. Jakub. (2002). Learning and credentialing in breast cancer sentinel lymph node biopsy. 5(1). 27–34.
15.
Jakub, James W., Nils M. Diaz, Mark Ebert, et al.. (2002). Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. The American Journal of Surgery. 184(4). 302–306. 42 indexed citations
16.
Cox, Charles E., Elisabeth Dupont, George F. Whitehead, et al.. (2002). Age and Body Mass Index May Increase the Chance of Failure in Sentinel Lymph Node Biopsy for Women with Breast Cancer. The Breast Journal. 8(2). 88–91. 107 indexed citations
17.
Dupont, Elisabeth, Charles E. Cox, Keoni Nguyen, et al.. (2001). Utility of Internal Mammary Lymph Node Removal When Noted by Intraoperative Gamma Probe Detection. Annals of Surgical Oncology. 8(10). 833–836. 34 indexed citations
18.
Cox, Charles E., Christopher Salud, Alan Cantor, et al.. (2001). Learning Curves for Breast Cancer Sentinel Lymph Node Mapping Based on Surgical Volume Analysis. Journal of the American College of Surgeons. 193(6). 593–600. 128 indexed citations
19.
Miguel, Rafael, Alan R. Shons, Mark Ebert, et al.. (2001). The Effect of Sentinel Node Selective Axillary Lymphadenectomy on the Incidence of Postmastectomy Pain Syndrome. Cancer Control. 8(5). 427–430. 41 indexed citations
20.
Ebert, Mark. (1998). Evaluation von Synergien bei Unternehmenszusammenschlüssen. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steffi Hartmann Breakdown of academic impact, for papers by Mediget Teshome Breakdown of academic impact, for papers by Lukas Rettenbacher Breakdown of academic impact, for papers by Christine Dauphine Breakdown of academic impact, for papers by Rauni Saaristo Breakdown of academic impact, for papers by F. Haddad Breakdown of academic impact, for papers by Kathryn Evers Breakdown of academic impact, for papers by Olga M. B. Gatewood Breakdown of academic impact, for papers by M. Pamilo Breakdown of academic impact, for papers by Leo J. Mahoney
Rankless by CCL
2026